Let’s talk about diabetes, heart disease, and CV risk reduction.
Did you know adults with diabetes are 2x more likely to have a heart attack or stroke? If you have diabetes or heart disease, read on to see how VASCEPA may help protect your heart.
Managing diabetes &
cardiovascular (CV) risk.
First things first. VASCEPA is not a diabetes medication. It's very important to continue taking your medication as directed by your doctor.
VASCEPA is an FDA-approved, prescription medicine that can give your heart added protection when taken with a statin.
VASCEPA can help manage your CV risk if you have diabetes or heart disease. That risk can be persistent and often elevated, especially since you may not realize just how at risk you may be.
In a recent survey of people age 45 and older with type 2 diabetes, only half recognize or have discussed their risk for heart attacks or strokes with their healthcare providers.
There’s no such thing as too much heart protection.
The question for your doctor shouldn’t be “do I have enough heart protection?” It should be “how can I get additional heart protection?”
That’s where VASCEPA can help. If you have heart disease or diabetes and raised triglycerides (≥150 mg/dL), VASCEPA can help lower your chance of a life-threatening heart attack or stroke by 25% when added to a statin.*
*In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%).
An “A” from the ADA!
In Standards of Medical Care in Diabetes for 2019, the American Diabetes Association (ADA) gave icosapent ethyl, marketed as VASCEPA, an "A" recommendation.
What does that mean? Generally, the ADA felt that the large clinical trial conducted with VASCEPA was well-designed and produced results that should be considered by physicians treating those with diabetes and cardiovascular (CV) disease or other CV risk factors on a statin with controlled bad cholesterol and elevated triglyceride levels.
In adults with diabetes and other risk factors, VASCEPA can make a heart health difference when added to a statin.
The “A” recommendation from ADA was based on the quality of the REDUCE-IT® trial and is not for comparison to other diabetes products.